{
    "3WD.F": {
        "short_name": "KANABO GROUP PLC  LS-,025",
        "long_name": "Kanabo Group Plc",
        "summary": "Kanabo Group Plc focuses on the research and development, production, and sale of medical cannabis products to treat CNS disorders. The company intends to offer cannabis-derived products for medical patients; and non-THC products for CBD consumers. It also provides VapePod, a medically certified delivery system for cannabis extracts. The company was founded in 2017 and is based in London, the United Kingdom.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Pharmaceutical Retailers",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United Kingdom",
        "state": null,
        "city": "London",
        "zipcode": "NW4 4DJ",
        "website": "http://www.kanabogroup.com",
        "market_cap": 81285744
    },
    "CBX.L": {
        "short_name": "CELLULAR GOODS PLC ORD GBP0.001",
        "long_name": "Cellular Goods PLC",
        "summary": "Cellular Goods PLC manufactures and sells biosynthetic cannabinoids-based consumer products in the United Kingdom. The company provides cannabinoid solutions for skin, movement, and daily living. It offers its products through retailers; direct to consumers through its website; and online. The company was formerly known as Leaf Studios PLC and changed its name to Cellular Goods PLC in September 2020. Cellular Goods PLC was incorporated in 2018 and is based in London, United Kingdom.",
        "currency": "GBp",
        "sector": "Healthcare",
        "industry": "Pharmaceutical Retailers",
        "exchange": "LSE",
        "market": "gb_market",
        "country": "United Kingdom",
        "state": null,
        "city": "London",
        "zipcode": "WC2B 5DG",
        "website": "http://www.cellulargoods.co",
        "market_cap": 34575376
    },
    "KNB.L": {
        "short_name": "KANABO GROUP PLC ORD 2.5P",
        "long_name": "Kanabo Group Plc",
        "summary": "Kanabo Group Plc focuses on the research and development, production, and sale of medical cannabis products to treat CNS disorders. The company intends to offer cannabis-derived products for medical patients; and non-THC products for CBD consumers. It also provides VapePod, a medically certified delivery system for cannabis extracts. The company was founded in 2017 and is based in London, the United Kingdom.",
        "currency": "GBp",
        "sector": "Healthcare",
        "industry": "Pharmaceutical Retailers",
        "exchange": "LSE",
        "market": "gb_market",
        "country": "United Kingdom",
        "state": null,
        "city": "London",
        "zipcode": "NW4 4DJ",
        "website": "http://www.kanabogroup.com",
        "market_cap": 72577800
    }
}